IBRX ImmunityBio, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 4, 2026
$10.29
· % 处于52周区间
· 高于低点
· 至高点
$1.9552周低点
$12.4352周高点
市值 (MRQ)
$10.83B
P/E (TTM)
-10.6
EPS (TTM)
$-0.97
收入 (TTM)
$166M
IBRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$10.29
市值 (MRQ)
$10.83B
P/E (TTM)
-10.6
EPS (TTM)
$-0.97
收入 (TTM)
$166M
ROE (TTM)
122.7%
52周区间
$2–$12
IBRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$113M2016-12-31 → 2025-12-31
EPS$-0.382019-12-31 → 2025-12-31
自由现金流$-309M2016-12-31 → 2025-12-31
净利率-598.6%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | IBRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -10.65年均值 ≈-5.1 | ≈-5.1 | · | · | |
| P/S (TTM) | 65.35年均值 ≈3415.1 | ≈3415.1 | 28.1 | 估值过高 | |
| 市净率 (MRQ) | -10.35年均值 ≈-5.8 | ≈-5.8 | · | · | |
| 股价/自由现金流 (TTM) | -37.65年均值 ≈-6.7 | ≈-6.7 | · | · | |
| 市现率 (TTM) | -38.55年均值 ≈-7.3 | ≈-7.3 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | IBRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -151.9%5年均值 ≈-48507.2% | ≈-48507.2% | -34.4% | 弱 | |
| 息税折旧摊销前利润率 (TTM) | -141.9%5年均值 ≈-46058.8% | ≈-46058.8% | -34.4% | 弱 | |
| 税前利润率 (TTM) | -598.7%5年均值 ≈-61662.8% | ≈-61662.8% | -42.3% | 弱 | |
| 净利润率 (TTM) | -598.6%5年均值 ≈-61515.1% | ≈-61515.1% | -42.8% | 弱 | |
| ROA (TTM) | -192.6%5年均值 ≈-101.6% | ≈-101.6% | -20.4% | 弱 | |
| ROE (TTM) | 122.7%5年均值 ≈114.6% | ≈114.6% | -23.4% | 顶尖 | |
| ROIC | 51.1%5年均值 ≈79.6% | ≈79.6% | -21.5% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | IBRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 5.75年均值 ≈2.9 | ≈2.9 | 6.5 | 低流动性 | |
| 速动比率 (MRQ) | 5.45年均值 ≈2.6 | ≈2.6 | 5.4 | 持平 | |
| Interest Coverage (利息保障倍数) | -4.25年均值 ≈-7.6 | ≈-7.6 | -13.2 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | IBRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 668.3%5年均值 ≈615.6% | ≈615.6% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 678.6%5年均值 ≈276.8% | ≈276.8% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 184.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | IBRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.35年均值 ≈0.1 | ≈0.1 | 0.2 | 顶尖 | |
| Inventory Turnover (库存周转率) | 0.2 | · | 1.1 | 弱 | |
| Receivables Turnover (应收账款周转率) | 5.0 | · | 6.6 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$165.6K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-13.6%
下次报告
十一月 02, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-0.22 | $-0.09 | -139.7% |
| 2026年3月31日 | 五月 11, 2026 | $-0.08 | $-0.07 | -12.0% |
| 2025年12月31日 | $-0.06 | $-0.10 | 37.4% | |
| 2025年9月30日 | $-0.07 | $-0.11 | 36.5% | |
| 2025年6月30日 | $-0.10 | $-0.11 | 10.9% | |
| 2025年3月31日 | $-0.15 | $-0.13 | -14.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $15M | $622.0K | $240.0K | $934.0K | $605.0K | $2M | $47.0K | $45.0K | $44.0K | $236.0K | $641.0K | |
| Cost of Revenue | $753.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $190M | $232M | $248M | $196M | $140M | $112M | $56M | $42M | $29M | $11M | $2M | |
| SG&A Expense | · | $169M | $130M | $103M | $135M | $71M | $46M | $43M | $57M | $95M | $228M | $5M | |
| Operating Expenses | $369M | $359M | $363M | $352M | $331M | $221M | $158M | $98M | $99M | $125M | $239M | $6M | |
| Operating Income | $-256M | $-344M | $-362M | $-351M | $-330M | $-221M | $-156M | $-98M | $-99M | $-124M | $-239M | $-6M | |
| Interest Expense | $61M | $115M | $129M | $64M | $15M | $9M | $6M | · | $618.0K | $66.0K | $0 | $471.0K | |
| Interest Income | · | · | · | · | · | $1M | $2M | $2M | $4M | $5M | $312.0K | $20.0K | |
| Other Non-op | $-2M | $-15.0K | $-2M | $-736.0K | $193.0K | $1M | $-534.0K | $236.0K | $157.0K | $88.0K | $77.0K | $0 | |
| Pretax Income | $-352M | $-414M | $-584M | $-417M | $-350M | $-226M | $-160M | $-97M | $-97M | $-121M | $-237M | $-6M | |
| Income Tax | $-135.0K | $0 | $-40.0K | $34.0K | $9.0K | $-2M | $-105.0K | $-503.0K | $-493.0K | $-572.0K | $-301.0K | $1.0K | |
| Net Income | $-351M | $-414M | $-583M | $-417M | $-347M | $-222M | $-158M | $-96M | $-96M | $-121M | $-237M | $-6M | |
| EPS (Basic) | $-0.38 | $-0.59 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · | |
| EPS (Diluted) | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · | |
| Shares (Basic) | 919,863,000 | 697,312,000 | 508,636,000 | 399,900,000 | 389,234,156 | 377,067,527 | 366,324,859 | · | · | · | · | · | |
| Shares (Diluted) | 919,863,000 | 700,443,000 | 508,636,000 | 399,900,000 | 389,234,156 | 377,067,527 | 366,324,859 | · | · | · | · | · | |
| EBITDA | $-241M | $-327M | $-344M | $-333M | $-316M | $-82M | $-59M | $-89M | $-94M | $-121M | $1M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $143M | $265M | $105M | $181M | $35M | $76M | $17M | $24M | $8M | $176M | $59M | |
| Short-term Investments | $154M | $6M | $1M | $3M | $136M | $61M | · | · | $104M | $191M | $118M | · | |
| Receivables | $43M | $2M | $0 | · | · | · | · | · | · | · | · | $145.0K | |
| Inventory | $910.0K | $8M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $29M | $24M | $26M | $32M | $16M | $14M | $4M | $14M | $4M | $5M | $3M | $124.0K | |
| Other Current Assets | $2M | $1M | $2M | $2M | $3M | $110.0K | $24.0K | $42.0K | $275.0K | $275.0K | $0 | · | |
| Current Assets | $315M | $185M | $294M | $141M | $334M | $112M | $56M | $89M | $132M | $205M | $298M | $59M | |
| PP&E (Net) | $114M | $137M | $146M | $144M | $83M | $73M | $61M | $77M | $77M | $19M | $6M | $211.0K | |
| PP&E (Gross) | $227M | $237M | $230M | $213M | $136M | $114M | $79M | $88M | $81M | $20M | $6M | $257.0K | |
| Accum. Depreciation | $112M | $100M | $84M | $69M | $53M | $42M | $19M | $12M | $4M | $1M | $167.0K | $46.0K | |
| Goodwill | $910.0K | $910.0K | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $13M | $15M | $17M | $20M | $1M | $1M | $0 | $565.0K | $3M | $5M | $7M | $3.0K | |
| Other Non-current Assets | · | $5M | $3M | $5M | $7M | $3M | $4M | $2M | $330.0K | $788.0K | $1M | $409.0K | |
| Total Assets | $502M | $383M | $504M | $362M | $469M | $221M | $143M | $182M | $250M | $317M | $367M | $61M | |
| Accounts Payable | · | · | · | $21M | $11M | $12M | $2M | $3M | $6M | $4M | $2M | $1M | |
| Accrued Liabilities | $47M | $41M | $43M | $42M | $51M | $37M | $5M | $21M | $11M | $6M | $3M | $311.0K | |
| Short-term Debt | · | · | $0 | $432M | · | · | · | · | · | · | · | $265.0K | |
| Current Liabilities | $62M | $55M | $58M | $501M | $369M | $68M | $12M | $27M | $21M | $13M | $6M | $2M | |
| Capital Leases | $33M | $35M | $40M | $48M | $37M | $16M | $11M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | $162.0K | $170.0K | · | $0 | $498.0K | $996.0K | $1M | · | |
| Other Non-current Liabilities | $424.0K | $319.0K | $1M | $457.0K | $411.0K | $1M | · | $0 | $255.0K | $240.0K | $0 | · | |
| Total Liabilities | $1.00B | $871M | $1.09B | $812M | $713M | $340M | $22M | $36M | $32M | $24M | $11M | $2M | |
| Total Debt | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $101.0K | $85.0K | $67.0K | $42.0K | $40.0K | $38.0K | $10.0K | $8.0K | $8.0K | $8.0K | $8.0K | · | |
| Retained Earnings | $-3.73B | $-3.38B | $-2.96B | $-2.38B | $-1.96B | $-1.62B | $-662M | $-595M | $-499M | $-387M | $-250M | $-13M | |
| AOCI | $29M | $1M | $10.0K | $183.0K | $4.0K | $122.0K | $-105.0K | $-267.0K | $-381.0K | $-284.0K | $-192.0K | · | |
| Stockholders' Equity | $-500M | $-489M | $-587M | $-447M | $-242M | $-120M | $121M | $146M | $219M | $293M | $356M | $58M | |
| Liabilities + Equity | $502M | $383M | $504M | $362M | $469M | $221M | $143M | $182M | $250M | $317M | $367M | $61M | |
| Shares Outstanding | 1,011,800,008 | 852,904,340 | 670,867,344 | 421,569,115 | 397,830,044 | 382,243,142 | 371,976,995 | 348,677,955 | 79,021,878 | 81,983,937 | 81,311,686 | · |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $18M | $19M | $18M | $14M | $13M | $14M | $10M | $6M | $4M | $1M | $36.0K | |
| Stock-based Comp | $37M | $34M | $49M | $40M | $57M | $2M | $3M | $23M | $37M | $74M | $211M | $789.0K | |
| Deferred Tax | $-139.0K | $0 | $-14.0K | $-4.0K | $-8.0K | $-3M | $-8.0K | $-498.0K | $-497.0K | $-575.0K | $-302.0K | $0 | |
| Amort. of Intangibles | · | $2M | $2M | $2M | · | · | $600.0K | $2M | $2M | $3M | $1M | $0 | |
| Other Non-cash | $-6M | $-30M | $149M | $21M | $960.0K | $11M | $-7M | $406.0K | $6M | $5M | $-820.0K | · | |
| Operating Cash Flow | $-305M | $-391M | $-367M | $-338M | $-274M | $-172M | $-152M | $-63M | $-49M | $-39M | $-25M | $-5M | |
| CapEx | $4M | $7M | $31M | $78M | $34M | $2M | $4M | $13M | $35M | $7M | $2M | $235.0K | |
| Investing Cash Flow | $-150M | $-12M | $-30M | $27M | $-85M | $-20M | $19M | $57M | $100M | $-114M | · | · | |
| Stock Issued | · | · | · | $60M | $165M | $86M | $30M | $0 | · | $0 | $0 | $1M | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $3M | $228.0K | $15M | $16M | $5M | $0 | |
| Net Stock Activity | · | · | · | $60M | $165M | $86M | $-501.0K | $-228.0K | $-15M | $-16M | $-5M | · | |
| Financing Cash Flow | $400M | $282M | $558M | $234M | $505M | $151M | $114M | $-771.0K | $-35M | $-16M | · | · | |
| Net Change in Cash | $-54M | $-122M | $161M | $-76M | $146M | $-41M | $-19M | · | $16M | $-168M | $117M | $59M | |
| Taxes Paid | $0 | $15.0K | $8.0K | $2.0K | $9.0K | $8.0K | $3.0K | $4.0K | $3.0K | $2.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-309M | $-398M | $-397M | $-416M | $-308M | $-73M | $-66M | $-76M | $-84M | $-45M | $-28M | · | |
| Levered FCF | $-370M | $-513M | $-527M | $-479M | $-323M | · | · | · | $-84M | $-45M | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% | -82546.0% | -157690.7% | -209338.3% | -220266.7% | -282954.6% | · | · | |
| Net Margin | -310.2% | -2804.8% | -93761.4% | -173569.6% | -37129.6% | -83227.9% | -152997.7% | -204736.2% | -214273.3% | -274565.9% | -100371.2% | · | |
| Pretax Margin | -310.4% | -2805.3% | -93873.3% | -173869.2% | -37456.0% | -83223.4% | -153223.3% | -205806.4% | -215368.9% | -275865.9% | · | · | |
| EBITDA Margin | -212.3% | -2215.2% | -55263.3% | -138765.8% | -33837.5% | -74305.4% | -136732.6% | -189008.5% | -207897.8% | -274756.8% | 623.7% | · | |
| ROA | -79.4% | -93.2% | -134.6% | -100.2% | -100.5% | -62.6% | -40.5% | -44.5% | -34.0% | -35.3% | · | · | |
| ROE | 71.0% | 76.9% | 112.8% | 120.8% | 191.6% | -64.4% | -51.3% | -62.5% | -37.6% | -37.2% | -114.5% | · | |
| ROIC | 51.1% | 70.4% | 61.7% | 78.5% | 136.4% | -78.0% | -56.1% | -67.0% | -45.1% | -42.2% | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 3.4 | 5.0 | 0.3 | 0.9 | 3.1 | 4.8 | 3.3 | 6.3 | 16.3 | · | · | |
| Quick Ratio | 4.6 | 2.8 | 4.6 | 0.2 | 0.9 | 0.5 | 1.3 | 0.6 | 6.1 | 15.8 | 47.9 | · | |
| Debt / Equity | · | · | 0.0 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -4.2 | -3.0 | -2.8 | -5.5 | -22.2 | · | · | · | -160.4 | -1886.4 | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.2 | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 5.0 | 12.5 | · | · | · | · | · | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.49 | $-0.57 | $-0.88 | $-1.06 | $-0.61 | $1.08 | $1.23 | $1.85 | $2.77 | $3.58 | · | · | |
| Revenue / Share | $0.12 | $0.02 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.33 | $-0.56 | $-0.72 | $-0.84 | $-0.70 | · | · | · | · | · | · | · | |
| Cash / Share | $0.09 | $0.17 | $0.40 | $0.25 | $0.46 | $0.11 | $0.16 | $0.21 | $0.30 | $0.10 | · | · | |
| EPS (TTM) | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 668.3% | 2270.6% | 159.2% | -74.3% | 54.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 678.6% | 150.9% | 0.93% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 184.8% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $113M | $15M | $622.0K | $240.0K | $934.0K | $605.0K | $2M | $47.0K | $45.0K | $44.0K | $236.0K | · | |
| Net Income TTM | $-351M | $-414M | $-583M | $-417M | $-347M | $-222M | $-158M | $-96M | $-96M | $-121M | $-237M | · | |
| Market Cap | $2.00B | $2.18B | $3.37B | $2.14B | $2.42B | $1.45B | $373M | $92M | $355M | $469M | · | · | |
| Enterprise Value | · | · | $3.10B | · | · | · | · | · | · | · | · | · | |
| P/E | -5.2 | -4.1 | -4.4 | -4.9 | -6.8 | -22.6 | -8.8 | · | · | · | · | · | |
| P/S | 17.7 | 148.1 | 5414.4 | 8905.6 | 2589.7 | 2395.6 | 169.5 | 1952.0 | 7884.6 | 10657.9 | · | · | |
| P/B | -4.0 | -4.5 | -5.7 | -4.8 | -10.0 | 12.3 | 3.1 | 0.6 | 1.6 | 1.6 | · | · | |
| P / Cash Flow | -6.6 | -5.6 | -9.2 | -6.3 | -8.8 | -20.6 | -6.1 | -1.4 | -7.3 | -12.2 | · | · | |
| P / FCF | -6.5 | -5.5 | -8.5 | -5.1 | -7.9 | -19.8 | -5.7 | -1.2 | -4.2 | -10.4 | · | · | |
| EV / EBITDA | · | · | -9.0 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -7.8 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 4986.0 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19.2% | -24.2% | -22.9% | -20.5% | -14.6% | -4.4% | -11.3% | · | · | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51M | $44M | $38M | $32M | $26M | $17M | $8M | $6M | $1M | $40.0K | $139.0K | $82.0K | $41.0K | $360.0K | $73.0K | $118.0K | |
| Cost of Revenue | $298.0K | $238.0K | $382.0K | $177.0K | $136.0K | $58.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | · | · | · | · | · | · | · | $50M | $51M | $53M | · | $48M | $53M | $79M | $58M | $72M | |
| SG&A Expense | · | · | · | · | · | · | · | $36M | $49M | $42M | · | $32M | $32M | $33M | $26M | $19M | |
| Operating Expenses | $113M | $114M | $103M | $88M | $98M | $81M | $77M | $86M | $100M | $95M | $86M | $80M | $85M | $112M | $85M | $91M | |
| Operating Income | $-62M | $-70M | $-65M | $-56M | $-71M | $-64M | $-69M | $-80M | $-99M | $-95M | $-85M | $-80M | $-85M | $-112M | $-85M | $-91M | |
| Interest Expense | · | · | $15M | $15M | $15M | $15M | $26M | $29M | $30M | $29M | $32M | $35M | $32M | $30M | $29M | $17M | |
| Other Non-op | $242.0K | $-6M | $-2M | $-187.0K | $-278.0K | $-41.0K | $10.0K | $12.0K | $-17.0K | $-20.0K | $-71.0K | $-1M | $-28.0K | $-1M | $-923.0K | $6.0K | |
| Pretax Income | $-230M | $-633M | $-62M | $-67M | $-92M | $-130M | $-59M | $-86M | $-135M | $-134M | $-233M | $-96M | $-138M | $-117M | $-108M | $-111M | |
| Income Tax | $0 | $9.0K | $-135.0K | $-35.0K | $269.0K | $-234.0K | $0 | $0 | $0 | $0 | $-40.0K | $0 | $0 | $0 | $34.0K | $0 | |
| Net Income | $-230M | $-633M | $-62M | $-67M | $-93M | $-130M | $-59M | $-86M | $-135M | $-134M | $-233M | $-96M | $-138M | $-116M | $-108M | $-111M | |
| EPS (Basic) | $-0.22 | $-0.62 | $-0.06 | $-0.07 | $-0.10 | $-0.15 | $-0.07 | $-0.12 | $-0.20 | $-0.20 | $-0.37 | $-0.19 | $-0.32 | $-0.27 | $-0.26 | $-0.28 | |
| EPS (Diluted) | $-0.22 | $-0.62 | $-0.06 | $-0.07 | $-0.10 | $-0.15 | $-0.08 | $-0.14 | $-0.20 | $-0.20 | $-0.37 | $-0.19 | $-0.32 | $-0.27 | $-0.26 | $-0.28 | |
| Shares (Basic) | 1,050,070,000 | 1,026,874,000 | · | 946,601,000 | 888,216,000 | 853,162,000 | · | 695,895,000 | 686,938,000 | 672,831,000 | · | 498,375,000 | 437,456,657 | 428,381,485 | · | 400,059,707 | |
| Shares (Diluted) | 1,050,070,000 | 1,026,874,000 | · | 946,601,000 | 888,216,000 | 853,162,000 | · | 697,961,000 | 686,938,000 | 672,831,000 | · | 498,375,000 | 437,456,657 | 428,381,485 | · | 400,059,707 | |
| EBITDA | $-62M | $-65M | · | $-56M | $-71M | $-61M | · | $-80M | $-99M | $-91M | · | $-80M | $-85M | $-107M | · | $-91M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $205M | $88M | $60M | $138M | $61M | $143M | $112M | $130M | $133M | $265M | $178M | $44M | $88M | $105M | $104M | |
| Short-term Investments | $282M | $176M | $154M | $198M | $16M | $931.0K | $6M | $18M | $88M | $37M | · | $12M | $2M | $3M | · | $7M | |
| Receivables | $53M | $43M | $43M | $32M | $22M | $17M | $2M | $4M | $1M | · | · | · | · | · | · | · | |
| Inventory | $2M | $547.0K | $910.0K | $7M | $7M | $8M | $8M | $2M | $2M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | $28M | $29M | $33M | $26M | $22M | $24M | $26M | $21M | $23M | · | $23M | $19M | $21M | · | $31M | |
| Other Current Assets | · | $3M | $2M | $3M | $2M | $2M | $1M | $1M | $480.0K | $3M | · | $4M | $5M | $4M | · | $3M | |
| Current Assets | $439M | $453M | $315M | $329M | $208M | $109M | $185M | $163M | $243M | $196M | · | $215M | $67M | $113M | · | $143M | |
| PP&E (Net) | $114M | $113M | $114M | $130M | $133M | $135M | $137M | $139M | $142M | $144M | · | $152M | $151M | $154M | · | $130M | |
| PP&E (Gross) | · | $229M | $227M | $239M | $239M | $238M | $237M | $235M | $234M | $232M | · | $233M | $229M | $228M | · | $195M | |
| Accum. Depreciation | · | $116M | $112M | $109M | $106M | $103M | $100M | $96M | $92M | $88M | · | $81M | $78M | $73M | · | $65M | |
| Goodwill | · | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | · | · | · | · | · | · | · | · | |
| Intangibles | · | $12M | $13M | $14M | $14M | $14M | · | $15M | $16M | $17M | · | $18M | $19M | $20M | · | $20M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $4M | $3M | $3M | · | $3M | $4M | $5M | · | $5M | |
| Total Assets | $629M | $647M | $502M | $519M | $402M | $304M | $383M | $365M | $444M | $401M | · | $432M | $291M | $343M | · | $353M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | $20M | |
| Accrued Liabilities | · | $48M | $47M | $44M | $36M | $28M | $41M | $44M | $35M | $33M | · | $65M | $62M | $54M | · | $46M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $482M | · | · | · | |
| Current Liabilities | $77M | $68M | $62M | $57M | $51M | $49M | $55M | $61M | $62M | $54M | · | $90M | $613M | $565M | · | $71M | |
| Capital Leases | $31M | $33M | $33M | $34M | $36M | $33M | $35M | $37M | $36M | $38M | · | $39M | $45M | $46M | · | $50M | |
| Other Non-current Liabilities | $510.0K | $472.0K | $424.0K | $702.0K | $710.0K | $370.0K | $319.0K | $705.0K | $704.0K | $1M | · | $467.0K | $473.0K | $462.0K | · | $569.0K | |
| Total Liabilities | $1.67B | $1.52B | $1.00B | $1.04B | $972M | $894M | $871M | $1.11B | $1.14B | $1.09B | · | $843M | $936M | $875M | · | $782M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $482M | · | · | · | |
| Common Stock | $105.0K | $104.0K | $101.0K | $98.0K | $91.0K | $85.0K | $85.0K | $70.0K | $69.0K | $68.0K | · | $67.0K | $44.0K | $43.0K | · | $40.0K | |
| Retained Earnings | $-4.59B | $-4.36B | $-3.73B | $-3.66B | $-3.60B | $-3.50B | $-3.38B | $-3.32B | $-3.23B | $-3.10B | · | $-2.73B | $-2.63B | $-2.49B | · | $-2.27B | |
| AOCI | $27M | $27M | $29M | $5M | $13M | $20M | $1M | $103.0K | $-8.0K | $-7.0K | · | $792.0K | $-40.0K | $-33.0K | · | $-190.0K | |
| Stockholders' Equity | $-1.05B | $-870M | $-500M | $-524M | $-571M | $-591M | $-489M | $-745M | $-698M | $-692M | · | $-412M | $-642M | $-529M | · | $-427M | |
| Liabilities + Equity | $629M | $647M | $502M | $519M | $402M | $304M | $383M | $365M | $444M | $401M | · | $432M | $291M | $343M | · | $353M | |
| Shares Outstanding | 1,053,221,645 | 1,047,341,146 | 1,011,800,008 | 984,965,179 | 915,625,053 | 853,556,193 | 852,904,340 | 696,831,296 | 691,793,169 | 677,003,411 | 670,867,344 | 667,703,040 | 440,673,897 | 421,569,115 | 421,569,115 | 400,304,106 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | |
| Stock-based Comp | $9M | $8M | $9M | $9M | $10M | $10M | $9M | $7M | $10M | $8M | $13M | $14M | $11M | $11M | $9M | $11M | |
| Amort. of Intangibles | · | · | · | · | $500.0K | $500.0K | · | $500.0K | $500.0K | $500.0K | · | $500.0K | $500.0K | $500.0K | $400.0K | $600.0K | |
| Other Non-cash | · | $545M | · | · | · | $30M | · | · | · | $14M | · | · | · | $16M | · | · | |
| Operating Cash Flow | $-66M | $-75M | $-70M | $-69M | $-80M | $-86M | $-85M | $-99M | $-100M | $-107M | $-115M | $-87M | $-80M | $-84M | $-91M | $-81M | |
| CapEx | $4M | $2M | $903.0K | $741.0K | $1M | $1M | $2M | $3M | $724.0K | $1M | $8M | $6M | $9M | $8M | $19M | $16M | |
| Investing Cash Flow | $-107M | $-32M | $44M | $-181M | $-16M | $4M | $10M | $65M | $-51M | $-36M | $2M | $-16M | $-9M | $-8M | $-19M | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $47M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $47M | · | · | |
| Financing Cash Flow | $44M | $224M | $55M | $174M | $173M | $-982.0K | $107M | $16M | $149M | $10M | $201M | $238M | $43M | $77M | $110M | $124M | |
| Net Change in Cash | $-130M | $117M | $28M | $-77M | $77M | $-83M | $32M | $-18M | $-3M | $-132M | $87M | $134M | $-45M | $-16M | $480.0K | $42M | |
| Taxes Paid | · | · | $0 | $0 | $0 | $0 | $0 | $2.0K | $5.0K | $8.0K | $8.0K | $0 | $0 | $0 | $-1.0K | $3.0K | |
| Free Cash Flow | · | $-77M | · | · | · | $-87M | · | · | · | $-108M | · | · | · | $-93M | · | · | |
| Levered FCF | · | · | · | · | · | $-102M | · | · | · | $-138M | · | · | · | $-123M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -120.4% | -157.9% | · | -173.5% | -269.8% | -390.1% | · | -1314.3% | -9487.4% | -237990.0% | · | -97726.8% | -207670.7% | -30994.4% | · | -76952.5% | |
| Net Margin | -449.6% | -1431.4% | · | -209.8% | -350.3% | -784.9% | · | -1404.0% | -12852.3% | -335272.5% | · | -116563.4% | -336290.2% | -32317.5% | · | -94015.2% | |
| Pretax Margin | -449.6% | -1431.5% | · | -209.9% | -349.3% | -786.5% | · | -1404.4% | -12854.2% | -335325.0% | · | -116636.6% | -337104.9% | -32384.2% | · | -94204.2% | |
| EBITDA Margin | -120.4% | -148.0% | · | -173.5% | -269.8% | -366.9% | · | -1314.3% | -9487.4% | -226602.5% | · | -97726.8% | -207670.7% | -29694.2% | · | -76952.5% | |
| ROA | -44.7% | -133.2% | · | -15.2% | -21.9% | -36.8% | · | -21.5% | -36.6% | -36.0% | · | -24.3% | -45.3% | -31.7% | · | -39.1% | |
| ROE | 28.5% | 86.6% | · | 10.6% | 14.6% | 20.2% | · | 14.8% | 20.1% | 22.0% | · | 22.8% | 26.0% | 26.9% | · | 36.1% | |
| ROIC | 5.9% | 8.0% | · | 10.6% | 12.5% | 10.9% | · | 10.8% | 14.2% | 13.8% | · | 19.5% | 53.1% | 21.1% | · | 21.3% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.7 | · | 5.8 | 4.1 | 2.2 | · | 2.7 | 3.9 | 3.6 | · | 2.4 | 0.1 | 0.2 | · | 2.0 | |
| Quick Ratio | 5.4 | 6.2 | · | 5.1 | 3.5 | 1.6 | · | 2.2 | 3.5 | 3.2 | · | 2.1 | 0.1 | 0.2 | · | 1.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | -0.8 | · | · | · | |
| Interest Coverage | · | · | · | -3.6 | -4.6 | -4.2 | · | -2.7 | -3.3 | -3.2 | · | -2.3 | -2.6 | -3.7 | · | -5.4 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.5 | · | 1.8 | 2.3 | 1.9 | · | 2.9 | 1.9 | · | · | · | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.99 | $-0.83 | · | $-0.53 | $-0.62 | $-0.69 | · | $-1.07 | $-1.01 | $-1.02 | · | $-0.62 | $-1.46 | $-1.25 | · | $-1.07 | |
| Revenue / Share | $0.05 | $0.04 | · | $0.03 | $0.03 | $0.02 | · | $0.01 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.07 | · | · | · | $-0.10 | · | · | · | $-0.16 | · | · | · | $-0.20 | · | · | |
| Cash / Share | $0.07 | $0.20 | · | $0.06 | $0.15 | $0.07 | · | $0.16 | $0.19 | $0.20 | · | $0.27 | $0.10 | $0.21 | · | $0.26 | |
| EPS (TTM) | $-0.97 | $-0.85 | · | $-0.40 | $-0.47 | $-0.57 | · | $-0.91 | $-0.96 | $-1.08 | · | $-1.04 | $-1.13 | $-1.05 | · | $-1.01 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $166M | $141M | · | $83M | $57M | $31M | · | $7M | $1M | $302.0K | · | $556.0K | $592.0K | $586.0K | · | $557.0K | |
| Net Income TTM | $-992M | $-855M | · | $-349M | $-367M | $-409M | · | $-588M | $-598M | $-601M | · | $-458M | $-473M | $-430M | · | $-400M | |
| Market Cap | $9.22B | $8.03B | · | $2.42B | $2.42B | $2.57B | · | $2.59B | $4.37B | $3.64B | · | $1.13B | $1.23B | $767M | · | $1.99B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $939M | $1.66B | · | · | · | |
| P/E | -9.0 | -9.0 | · | -6.2 | -5.6 | -5.3 | · | -4.1 | -6.6 | -5.0 | · | -1.6 | -2.5 | -1.7 | · | -4.9 | |
| P/S | 55.6 | 57.0 | · | 29.4 | 42.7 | 82.3 | · | 353.5 | 3342.6 | 12038.1 | · | 2029.5 | 2069.4 | 1309.3 | · | 3571.8 | |
| P/B | -8.8 | -9.2 | · | -4.6 | -4.2 | -4.3 | · | -3.5 | -6.3 | -5.3 | · | -2.7 | -1.9 | -1.5 | · | -4.7 | |
| P / Cash Flow | · | -106.6 | · | · | · | -29.9 | · | · | · | -34.0 | · | · | · | -9.1 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1688.2 | 2805.8 | · | · | · | |
| Earnings Yield | -11.1% | -11.1% | · | -16.3% | -17.8% | -18.9% | · | -24.5% | -15.2% | -20.1% | · | -61.5% | -40.6% | -57.7% | · | -20.3% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $113M | $15M | $622.0K | $240.0K | $934.0K |
| 营业利润率 % | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% |
| 净收入 | $-351M | $-414M | $-583M | $-417M | $-347M |
| 稀释后每股收益 (EPS) | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | · | · | 0.0 | · | · |
| 流动比率 | 5.1 | 3.4 | 5.0 | 0.3 | 0.9 |
| 速动比率 | 4.6 | 2.8 | 4.6 | 0.2 | 0.9 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-309M | $-398M | $-397M | $-416M | $-308M |
机构持有人 (13F) 447 家申报者 · $2.0B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
447
持有价值
$2.0B
新仓位
70
已退出持仓
45
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 70 (-104 与上一季度对比) | 45 (+16 与上一季度对比) | 147 (+6 与上一季度对比) | 110 (+52 与上一季度对比) | +21.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $298398958 | 34083262 | 14.71% | 股份 |
| STATE STREET CORP | $187343325 | 21398438 | 9.24% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $156398541 | 17863911 | 7.71% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $137379774 | 15691579 | 6.77% | 股份 |
| D. E. Shaw & Co., Inc. | $101129171 | 11551019 | 4.99% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $97155163 | 11097106 | 4.79% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $86230624 | 9847896 | 4.25% | 股份 |
| VANGUARD GROUP INC | $64898969 | 32777257 | 3.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58057776 | 6627600 | 2.86% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $48851088 | 5579793 | 2.41% | 股份 |
| LMR Partners LLP | $34879045 | 3983900 | 1.72% | 买入期权 |
| CITADEL ADVISORS LLC | $33592060 | 3836900 | 1.66% | 买入期权 |
| NORTHERN TRUST CORP | $31213746 | 3565248 | 1.54% | 股份 |
| MORGAN STANLEY | $30053096 | 3432678 | 1.48% | 股份 |
| GOLDMAN SACHS GROUP INC | $28316099 | 3234277 | 1.40% | 股份 |
| UBS Group AG | $27978598 | 3195728 | 1.38% | 股份 |
| GREAT POINT PARTNERS LLC | $26272004 | 3000800 | 1.30% | 卖出期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25289754 | 2888607 | 1.25% | 股份 |
| Woodline Partners LP | $21889155 | 2500189 | 1.08% | 股份 |
| SEB Asset Management AB | $21424757 | 2447150 | 1.06% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $21120019 | 2412338 | 1.04% | 股份 |
| BANK OF AMERICA CORP /DE/ | $19125201 | 2184489 | 0.94% | 股份 |
| JANE STREET GROUP, LLC | $17547647 | 2004300 | 0.87% | 买入期权 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $15075252 | 1721902 | 0.74% | 股份 |
| FEDERATED HERMES, INC. | $14999066 | 1713200 | 0.74% | 股份 |
| CITADEL ADVISORS LLC | $14898384 | 1701700 | 0.73% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14700156 | 1678100 | 0.72% | 卖出期权 |
| ROYAL BANK OF CANADA | $13506000 | 1542717 | 0.67% | 股份 |
| JPMORGAN CHASE & CO | $12871781 | 1450180 | 0.63% | 股份 |
| Bank of New York Mellon Corp | $11510727 | 1314760 | 0.57% | 股份 |
| FIRST TRUST ADVISORS LP | $10634409 | 1214667 | 0.52% | 股份 |
| Cetera Investment Advisers | $9984867 | 1140476 | 0.49% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $9012388 | 1029399 | 0.44% | 股份 |
| LPL Financial LLC | $8939354 | 1021057 | 0.44% | 股份 |
| OSAIC HOLDINGS, INC. | $7670411 | 875621 | 0.38% | 股份 |
| Nuveen, LLC | $7525903 | 859612 | 0.37% | 股份 |
| Pictet Asset Management Holding SA | $7433121 | 847659 | 0.37% | 股份 |
| Squarepoint Ops LLC | $6662494 | 760993 | 0.33% | 股份 |
| WELLS FARGO & COMPANY/MN | $6452703 | 737031 | 0.32% | 股份 |
| BARCLAYS PLC | $6394093 | 730336 | 0.32% | 股份 |
| Swiss National Bank | $6321110 | 722000 | 0.31% | 股份 |
| Clearwater Capital Advisors, LLC | $6281923 | 717524 | 0.31% | 股份 |
| Trexquant Investment LP | $6098269 | 696547 | 0.30% | 股份 |
| ALLEN HOLDING INC /NY | $6019684 | 687571 | 0.30% | 股份 |
| Kercheville Advisors, LLC | $5644219 | 644685 | 0.28% | 股份 |
| FRANKLIN RESOURCES INC | $5097004 | 582182 | 0.25% | 股份 |
| CITIGROUP INC | $4817667 | 550276 | 0.24% | 股份 |
| Voleon Capital Management LP | $4807598 | 549126 | 0.24% | 股份 |
| D.A. DAVIDSON & CO. | $4718279 | 538924 | 0.23% | 股份 |
| SHEETS SMITH WEALTH MANAGEMENT | $4487568 | 512572 | 0.22% | 股份 |
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Cambridge Equities, LP, MP 13 Ventures, LLC, NantWorks, LLC, Nant Capital, LLC, California Capital Equity, LLC, Patrick Soon-Shiong ×5 申报 | 2026年8月6日 | 64.80% | 修订 | · | SEC |
| Cambridge Equities, LP (2), MP 13 Ventures, LLC (2), NantWorks, LLC (2), NantMobile, LLC (2), Nant Capital, LLC (2), California Capital Equity, LLC (2), Patrick Soon-Shiong (2) ×9 申报 | 2024年1月4日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 20 位内幕人士 · 6 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Richard Adcock | CEO & President | 2026年2月22日 M | 560344 | 0 | 0 | $0 |
| David C. Sachs | Chief Financial Officer | 2026年2月22日 M | 300143 | 0 | 0 | $0 |
| Sonja Nelson | Chief Financial Officer | 2021年1月12日 M | 15410 | 0 | 0 | $0 |
| Richard J. Tajak | Chief Financial Officer | 2017年3月23日 M | 12876 | 0 | 0 | $0 |
| Angela Wilson | Chief Financial Officer | 2015年12月10日 P | 3265 | 0 | 0 | $0 |
| Regan J Lauer | Chief Accounting Officer | 2026年2月22日 M | 115875 | 0 | 0 | $0 |
| Cheryl Cohen | 董事 | 2026年7月2日 M | 125386 | 0 | 1 | $-1246495 |
| Christobel Selecky | 董事 | 2026年7月1日 M | 0 | 0 | 6 | $-2997697 |
| Barry J. Simon | 董事 | 2026年6月24日 S | 2802788 | 0 | 7 | $-4141241 |
| Linda Maxwell | 董事 | 2026年6月9日 A | · | 0 | 0 | $0 |
| Michael D Blaszyk | 董事 | 2026年6月9日 A | 71915 | 0 | 0 | $0 |
| Bruce Wendel | 董事 | 2026年6月9日 A | · | 0 | 0 | $0 |
| Wesley Clark | 董事 | 2026年6月9日 A | 8000 | 0 | 0 | $0 |
| John C Thomas | 董事 | 2020年12月10日 S | 207477 | 0 | 0 | $0 |
| Frederick W Driscoll | 董事 | 2020年8月11日 S | 109235 | 0 | 0 | $0 |
| Steve Gorlin | 董事 | 2020年6月10日 A | 92592 | 0 | 0 | $0 |
| Richard Kusserow | 董事 | 2017年6月9日 A | 394053 | 0 | 0 | $0 |
| John T Potts JR | 董事 | 2017年6月9日 A | 159253 | 0 | 0 | $0 |
| Patrick Soon-Shiong | · | 2025年2月10日 A | · | 0 | 0 | $0 |
| John Owen Brennan | · | 2024年6月11日 A | 25000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 35 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IDNA · iShares Trust | 2.82% | 934908 SH | 2026年9月11日 | 每日 |
| BBP · ETFis Series Trust I | 1.39% | 191148 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.66% | 74882 SH | 2026年10月2日 | 每日 |
| FNY · First Trust Exchange-Traded Alpha... | 0.65% | 524194 NS | 2026年7月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.61% | 423471 NS | 2026年7月31日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.53% | 231217 SH | 2026年10月2日 | 每日 |
| FNX · First Trust Exchange-Traded Alpha... | 0.25% | 470597 NS | 2026年7月31日 | N-PORT |
| IBB · iShares Trust | 0.21% | 2871255 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.20% | 414467 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.20% | 3629373 SH | 2026年9月11日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.20% | 157387 NS | 2026年7月31日 | N-PORT |
| PWS · Pacer Funds Trust | 0.17% | 5786 NS | 2026年7月31日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 390556 SH | 2026年8月19日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.11% | 102487 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 2224716 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.10% | 9868418 SH | 2026年9月11日 | 每日 |
| ISCG · iShares Trust | 0.10% | 119028 SH | 2026年9月11日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 4852894 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.09% | 185076 NS | 2026年7月31日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.07% | 62633 NS | 2026年7月31日 | N-PORT |
| TECB · iShares Trust | 0.06% | 36976 SH | 2026年9月11日 | 每日 |
| ESML · iShares Trust | 0.05% | 182507 SH | 2026年9月11日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.05% | 1082841 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.04% | 8407771 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 170988 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 3724582 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.03% | 24490 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 56428 SH | 2026年10月2日 | 每日 |
| IWV · iShares Trust | 0.00% | 105730 SH | 2026年9月11日 | 每日 |
| ITOT · iShares Trust | 0.00% | 437718 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.00% | 948 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 11599962 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 31790 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 17015 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 57890 SH | 2026年9月11日 | 每日 |
IBRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 10 位分析师
买入
中位数目标
$12.00
+16.7%
4 40.0%
强烈买入
5 50.0%
买入
1 10.0%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
3 位分析师 · 2026-10-04平均目标 $13.00 +26.4%
← 低于所有目标
当前价格 $10.29
最低$12.00
平均值$13.00
最高$15.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | · |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | · |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | · |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
最新新闻 提及该公司的近期头条新闻
ImmunityBio (IBRX): One of the Best Performing Growth Stocks So Far in 2026
Yahoo Finance · 3 月，3 周 前
ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy Now
Yahoo Finance · 3 月，3 周 前
ImmunityBio 股价今日为何飙升
Yahoo Finance · 4 月，1 周 前
ImmunityBio 股价周一暴跌原因
Nasdaq · 5 月，3 周 前
ImmunityBio Inc. (IBRX) 宣布 ANKTIVA® 在澳门特别行政区，中国获得批准
Yahoo Finance · 6 月，1 周 前
ImmunityBio (IBRX) 宣布 NCCN 更新临床实践指南，将 ANKTIVA 纳入乳头状单发 NMIBC
Yahoo Finance · 6 月，1 周 前
今日股市：石油、人工智能和私人信贷担忧拖累市场
Nasdaq · 6 月，1 周 前
ImmunityBio 股价今日下跌逾 20% 的原因
Yahoo Finance · 6 月，1 周 前
Jim Cramer 谈 ImmunityBio：“该股票属于‘魔法思维’时代”
Yahoo Finance · 6 月，1 周 前
ImmunityBio ( IBRX ) 跌 17% 获利 - 盘中高点后
finance.yahoo.com · 7 月 前
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 4, 2026 申报